---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-103761"
form_type: "8-K"
ticker: "JBIO"
cik: "0001798749"
company_name: "Jade Biosciences, Inc."
filed_at: "2025-04-29T23:59:59+00:00"
generated_at: "2026-05-23T04:02:49.677190+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Jade Biosciences provides updated corporate presentation; no material new details disclosed

## Summary
- Company changed name from Aerovate Therapeutics to Jade Biosciences, effective prior to this filing; trades under ticker JBIO on Nasdaq.
- Updated corporate presentation posted on company website on April 29, 2025; no financial or operational updates provided in the 8-K or exhibit.
- Presentation appears to be a Company Overview slide with disclaimers; no new specific data (revenue, pipeline, guidance) disclosed.

## SEC filing metadata
- accession: 0001193125-25-103761
- form_type: 8-K
- ticker: JBIO
- cik: 0001798749
- company_name: Jade Biosciences, Inc.
- filed_at: 2025-04-29T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1798749/000119312525103761/0001193125-25-103761-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1798749/000119312525103761/d938753d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-103761
- JSON: https://secwatch.observer/filing/0001193125-25-103761.json
- Plain text: https://secwatch.observer/filing/0001193125-25-103761.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.